The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/ pharmaceutical (BCP) customer partnership meeting to be held on June 6, 2012. The proposed agenda is as follows:
Morning Session
• Opening Remarks (9:00 - 9:15 am ET): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
• AIA Update (9:15 - 10:15 am): Janet Gongola, Patent Reform Coordinator
• Break (10:15 - 10:30 am)
• Cooperation Patent Classification Overview (10:30 - 11:15 am): Bruce Kisliuk, Deputy Commissioner for Patent Administration
• Claim Interpretation (11:15 am - 12:15 pm): Jeffrey Lundgren, SPE, Art Unit 1629
• Lunch (12:15 – 1:30 pm)
Afternoon Session
• Mayo v. Prometheus (1:30 - 3:00 pm): Roberte Makowski, Connolly Bove Lodge & Hutz, LLP, and Hans Sauer, Associate General Counsel for BIO
• Break (3:00 - 3:15 pm)
• Range Limitations in Claims (3:15 - 4:15 pm): Jean Witz, QAS, TC1600
• Closing Remarks/Discussion (4:15 - 4:30 pm): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Madison Auditorium, 600 Dulany Street, Alexandria, VA, or viewed online (we will post a link as soon as one is provided). Those wishing to attend the meeting should contact Cecilia Tsang by phone at 571-272-0562, by fax at 571-273-0562, or by e-mail at Cecilia.Tsang@uspto.gov by June 4, 2012 to confirm their attendance. Additional information regarding the BCP customer partnership meeting can be found here.
Comments